Article
Comparison of the TCR zeta-chain with the FcR gamma-chain in chimeric TCR constructs for T cell activation and apoptosis.
Cancer immunology, immunotherapy : CII - 1 Oct 2002
Ren-Heidenreich Lifen, Mordini Ryan, Hayman G Thomas, Siebenlist Ruth, LeFever Ann
Abstract excerpt
A promising strategy for cancer treatment is adoptive gene therapy/immunotherapy by genetically modifying T cells with a chimeric T cell receptor (cTCR). When transduced T cells (T-bodies) specifically bind to tumor antigens through cTCR, they will become cytotoxic T lymphocytes (CTL) and lyse the tumor cells in a non-major histocompatibility complex (MHC)-restricted manner. Both the FcR gamma-chain and the TCR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
